BBVA funds IBEC research into more efficient cancer drug delivery systems
An IBEC project has won funding from the BBVA Foundation under its ‘Ayudas a Equipos de Investigación en Biomedicina’ funding programme.
An IBEC project has won funding from the BBVA Foundation under its ‘Ayudas a Equipos de Investigación en Biomedicina’ funding programme.ICREA research professor Samuel Sánchez’s Smart Nano-Bio-Devices group will receive the support for three years to develop their project ‘MEDIROBOTS: Precision nanobotomy against tumors’.
The project will develop biocompatible robots driven by enzymes with applications as drug release systems whose progress in vitro and in vivo can be traced using advanced molecular imaging techniques such as super-resolution microscopy.
IBEC’s Biomaterials for Regenerative Therapies group has published a review of the state-of-the-art in biomaterials for skin healing that proposes a move towards more personalized, in situ therapies.
A ‘Results in Brief’ article about Elena Martinez’s ERC project COMIET has been published on the CORDIS website, the EC’s Community Research and Development Information Service.
Joan Montero, a senior researcher in IBEC’s Nanobioengineering group, appeared yesterday in an interview published by the SINC Agency in which he talks about his laboratory test – which is already being used in some hospitals in the United States – which is capable of predicting, in just 24 hours, if a drug will be able to kill a tumor.
Last month IBEC Director Josep Samitier was one of the panelists in a round table organised by the Cercle de Salut, an association devoted to improving the health system so that it may respond adequately to the challenges posed by society.